33.08

3.47% 1.1234

Baxter International Inc (BAX)

Overview News Price History Option Chain Financials Why BAX Down? Discussions Forecast Stock Split Dividend History

Baxter International Inc stock is traded at $33.08, with a volume of 4.03M. It is up +3.47% in the last 24 hours and down -10.28% over the past month. Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. It has signed an agreement to sell its kidney care segment by early 2025.

Previous Close:

$31.96

Open:

$31.77

24h Volume:

4.03M

Relative Volume:

1.18

Market Cap:

$16.44B

Revenue:

$15.00B

Net Income/Loss:

$2.48B

P/E Ratio:

6.4869

EPS:

5.1

Net Cash Flow:

$514.00M

1W Performance:

-3.36%

1M Performance:

-10.28%

6M Performance:

-6.18%

1Y Performance:

-6.74%

1-Day Range:

$31.75

$33.22

1-Week Range:

$31.60

$34.22

52-Week Range:

$31.60

$44.01

Baxter International Inc Stock (BAX) Company Profile

Name

Baxter International Inc

Sector

Healthcare (1200)

Industry

Medical Instruments & Supplies (58)

Phone

(847) 948-2000

Address

ONE BAXTER PKWY, DEERFIELD, IL

Employee

60,000

Twitter

@baxter_intl

Next Earnings Date

2024-11-08

Latest SEC Filings

BAX's Discussions on Twitter

Compare BAX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BAX	33.09	16.44B	15.00B	2.48B	514.00M	5.10
ISRG	531.92	190.83B	7.87B	2.24B	586.00M	4.25
BDX	224.57	65.14B	20.18B	1.73B	3.07B	5.51
ALC	85.93	42.50B	9.76B	1.16B	665.00M	0.72
RMD	238.99	35.17B	4.81B	1.11B	1.35B	6.16
WST	306.62	22.30B	2.88B	499.60M	321.60M	7.41

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
May-30-24	Initiated	Goldman	Neutral
May-10-24	Downgrade	TD Cowen	Buy → Hold
May-30-23	Resumed	Morgan Stanley	Equal-Weight
Mar-29-23	Initiated	UBS	Neutral
Jan-06-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-05-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-03-23	Downgrade	BofA Securities	Buy → Neutral
Dec-19-22	Downgrade	JP Morgan	Overweight → Neutral
Dec-15-22	Downgrade	Deutsche Bank	Buy → Hold
Dec-12-22	Downgrade	Citigroup	Buy → Neutral
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Hold
Jun-24-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-04-22	Downgrade	Goldman	Neutral → Sell
Mar-02-22	Resumed	BofA Securities	Buy
Feb-18-22	Reiterated	KeyBanc Capital Markets	Overweight
Feb-18-22	Reiterated	Morgan Stanley	Overweight
Feb-18-22	Reiterated	Raymond James	Outperform
Feb-18-22	Reiterated	Stifel	Buy
Feb-18-22	Reiterated	UBS	Neutral
Feb-18-22	Reiterated	Wells Fargo	Overweight
Feb-11-22	Initiated	Goldman	Neutral
Jan-07-22	Resumed	Citigroup	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-13-21	Upgrade	Cowen	Market Perform → Outperform
Sep-03-21	Upgrade	Barclays	Equal Weight → Overweight
May-25-21	Initiated	Barclays	Equal Weight
Jan-29-21	Downgrade	Piper Sandler	Overweight → Neutral
Jan-06-21	Downgrade	UBS	Buy → Neutral
Dec-15-20	Downgrade	Goldman	Buy → Neutral
Oct-01-20	Upgrade	Citigroup	Neutral → Buy
Sep-04-20	Downgrade	Argus	Buy → Hold
Jun-24-20	Initiated	Oppenheimer	Outperform
Mar-19-20	Upgrade	Stifel	Hold → Buy
Mar-18-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-05-20	Initiated	Citigroup	Neutral
Feb-13-20	Initiated	Goldman	Buy
Jan-02-20	Upgrade	Evercore ISI	In-line → Outperform
Dec-17-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-26-19	Initiated	KeyBanc Capital Markets	Sector Weight
Apr-08-19	Downgrade	Evercore ISI	Outperform → In-line
Jan-02-19	Upgrade	Citigroup	Neutral → Buy
Jan-02-19	Upgrade	Morgan Stanley	Underweight → Overweight
Nov-02-18	Upgrade	Argus	Hold → Buy
Oct-16-18	Initiated	Barclays	Underweight
May-17-18	Resumed	Piper Jaffray	Overweight
Feb-06-18	Reiterated	Citigroup	Neutral
Jan-03-18	Initiated	Evercore ISI	Outperform
Jan-03-18	Upgrade	Raymond James	Mkt Perform → Outperform

View All

Baxter International Inc Stock (BAX) Latest News

10:11 AM

Baxter International providing updates on recovery efforts after Helene - WCNC.com

10:11 AM

06:09 AM

Baxter International Inc. (NYSE:BAX) Shares Sold by Cincinnati Financial Corp - MarketBeat

06:09 AM

Nov 16, 2024

Baxter: Deleveraging At A Very Steep Price - Seeking Alpha

Nov 16, 2024

Nov 15, 2024

Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL

Nov 15, 2024

Baxter International Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Nov 15, 2024

Baxter International on track for end-of-year recovery goal after Helene - WCNC.com

Nov 15, 2024

Baxter put volume heavy and directionally bearish - TipRanks

Nov 15, 2024

Nov 14, 2024

Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Nov 14, 2024

Baxter International (NYSE:BAX) Sets New 52-Week LowHere's Why - MarketBeat

Nov 14, 2024

Sivik Global Healthcare LLC Has $5.70 Million Stock Position in Baxter International Inc. (NYSE:BAX) - MarketBeat

Nov 14, 2024

Baxter stock touches 52-week low at $32.4 amid market shifts - Investing.com Canada

Nov 14, 2024

Baxter International Inc. (NYSE:BAX) Shares Purchased by Entropy Technologies LP - MarketBeat

Nov 14, 2024

Entropy Technologies LP Purchases 15,794 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat

Nov 14, 2024

Nov 13, 2024

Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Nov 13, 2024

Baxter to Present at Jefferies London Healthcare Conference - Marketscreener.com

Nov 13, 2024

Baxter to split into two companies - Covington News

Nov 13, 2024

Baxter International To Present At UBS Global Healthcare Conference; Webcast At 4:15 PM ET - Nasdaq

Nov 13, 2024

Decoding Baxter International Inc (BAX): A Strategic SWOT Insight - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Nov 12, 2024

Baxter to Present at Stifel 2024 Healthcare Conference - Marketscreener.com

Nov 12, 2024

Baxter Cuts Dividend by 41% Ahead of Kidney-Care Unit Sale - MarketWatch

Nov 12, 2024

Baxter International Inc. Declares Quarterly Dividend, Payable on January 2, 2025 - Marketscreener.com

Nov 12, 2024

Nov 11, 2024

Baxter Sets $0.17 Dividend Ahead of Kidney Care Sale to Carlyle; 93-Year Payout Streak Continues | CG Stock News - StockTitan

Nov 11, 2024

Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR – S&S Insider - GlobeNewswire Inc.

Nov 11, 2024

Stifel Nicolaus Lowers Baxter International (NYSE:BAX) Price Target to $38.00 - MarketBeat

Nov 11, 2024

Baxter International Becomes Oversold - Nasdaq

Nov 11, 2024

Company news: Gaganjot Gill of Baxter International recognized by MACNY - syracuse.com

Nov 11, 2024

Baxter Declares Quarterly Dividend - Baxter

Nov 11, 2024

Plasma Expander Market Is Booming Worldwide 2024-2031 | Baxter - openPR

Nov 11, 2024

Nov 09, 2024

Earnings call: Baxter International sees steady growth and recovery post-Hurricane - Investing.com India

Nov 09, 2024

Baxter International (NYSE:BAX) Issues Quarterly Earnings Results - MarketBeat

Nov 09, 2024

Baxter International Inc. (NYSE:BAX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024